IOL Chemicals and Pharmaceuticals Limited (IOLCP) reports a 11.5% revenue increase and a 68.2% surge in PAT for Q4 & FY26.
Windlas Biotech Limited (WINDLAS) reports Q4 & FY26 results with 18% YoY revenue growth, Rs. 31.60 EPS, and strong net liquidity.
Max Healthcare Institute Limited (MAXHEALTH) reports a 10% YoY revenue rise to ₹2,664 Cr in Q4 FY26, with Network Operating EBITDA up 8% to ₹682 Cr.
Take Solutions Limited (NSE: TAKE) reports a strong financial performance for FY26 with ₹6,087 Lakhs consolidated total income.
Apollo Hospitals Enterprise Limited combines Apollo Cradle and Fertility with Cloudnine, forming India’s largest integrated maternity and fertility care plat.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) reports Q4 & FY26 results with highest-ever quarterly revenue and significant EBITDA margin growth.
Kopran Limited (KOPRAN) unveils its FY 2025-26 corporate presentation, highlighting significant financial and operational milestones.
Glenmark Pharmaceuticals Limited announces new development candidate ISB 2301, a first-in-class multispecific immune cells activator targeting solid tumors.
Shaily Engineering Plastics Limited (SHAILY) secures USFDA, Health Canada, and Indian regulatory approval for a generic Semaglutide injection using its innov.
Dishman Carbogen Amcis Limited (DCAL) reports a 18.9% revenue increase in Q4 FY26, driven by growth in CDMO and Marketable Molecules segments.